Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Fludarabine, Cytarabine, and Attenuated-Dose Idarubicin (m-FLAI) Induction for Elderly Patients with Acute Myeloid Leukemia: Results of a Multicenter Phase II Study,

Blood (2011) 118 (21): 3626.

https://doi.org/10.1182/blood.V118.21.3626.3626

Published: 2011

Journal Articles

Increased Copy Number of Interleukin-6 Receptor Gene Is Associated with Adverse Survival In Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation

Seon Young Kim, MD, Hyun Jung Min, Hyun Kyung Park, MD, Bora Oh, Tae Young Kim, Hyun Kyung Kim, MD, PhD, Inho Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Dong Soon Lee, MD, PhD

Blood (2010) 116 (21): 1895.

https://doi.org/10.1182/blood.V116.21.1895.1895

Published: 2010

Journal Articles

Bortezomib Resistant Multiple Myeloma Cells Are Tumor Initiating Cells That Have a Stem Cell-Like Genetic Signature.

Juwon Park, MS, Chansu Lee, BS, Jeong-In Oh, BS, Byung-Su Kim, MD, Jung Hye Kwon, MD, Byoung Kook Kim, MD, Kwang-Sung Ahn, Ph.D., Sung-Soo Yoon, MD

Blood (2009) 114 (22): 2805.

https://doi.org/10.1182/blood.V114.22.2805.2805

Published: 2009

Journal Articles

FLT3, CD32, PU.1, ERG, uPAR, and TAP2 Are Strongly Associated with the Progression of Chronic Myeloid Leukemia and Combination of Small Interference RNA of FLT3 and STI571 Synergistically Induced Apoptosis of K562 Cells

Kyung Im Kim, MS, Kwang-Sung Ahn, Ph.D., Juwon Park, MS, Chansu Lee, BS, Byoung Kook Kim, MD, Young-Yiul Lee, MD, Jung Mi Oh, Pharm.D., Sung-Soo Yoon

Blood (2008) 112 (11): 4237.

https://doi.org/10.1182/blood.V112.11.4237.4237

Published: 2008

Journal Articles

Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms of Both Donor and Recipient Can Modify the Rate of Recurrence in Allogeneic Hematopoietic Stem Cell Transplantation.

So Yeon Oh, MD, Hye Jin Kim, MD, Hyeon Gyu Yi, MD, Jin Won Kim, MD, Cheng Zhe Piao, PhD, Chongwon Chang, Eunsoon Shin, PhD, Inho Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD

Blood (2007) 110 (11): 4933.

https://doi.org/10.1182/blood.V110.11.4933.4933

Published: 2007

Journal Articles

DAAM2 Polymorphism and Allogeneic Hematopoietic Stem Cell Transplantation.

Hyeon Gyu Yi, MD, Cheng Zhe Piao, PhD, Inho Kim, MD, PhD, Hye Jin Kim, MD, So Yeon Oh, MD, Jin Won Kim, MD, Dae-Young Kim, MD, Joo Han Lim, MD, Myung-Deok Seo, MD, Seonyang Park, MD, Sung-Soo Yoon, MD, PhD, Byoung Kook Kim, MD, PhD, Chul Soo Kim, MD, PhD

Blood (2007) 110 (11): 2986.

https://doi.org/10.1182/blood.V110.11.2986.2986

Published: 2007

Journal Articles

Human Leukocyte Antigens of A33, B58 or DR7 Decrease the Treatment-Related Mortality in HLA-Matched Sibling Hematopoietic Stem Cell Transplantation in Association with Heat Shock Protein 70-Hom Polymorphisms.

Jin Won Kim, MD, So Yeon Oh, MD, Hye Jin Kim, MD, Hyeon Gyu Yi, MD, Kyung-Hun Lee, MD, Ji Young Rhee, MD, Eun-Soon Shin, PhD, Cheng Zhe Piao, PhD, Inho Kim, MD, Sung-Soo Yoon, MD, Myoung Hee Park, MD, Seonyang Park, MD, Byoung Kook Kim, MD

Blood (2007) 110 (11): 1103.

https://doi.org/10.1182/blood.V110.11.1103.1103

Published: 2007

Journal Articles

Pharmacokinetics and Tolerability of Intravenous Busulfan in Hematopoietic Stem Cell Transplantation.

Sung-Soo Yoon, MD, PhD, Yo-Han Cho, MD, Hyun-Ae Lim, Inho Kim, MD, Soo-Mee Bang, MD, Jong Seok Lee, MD, Seonyang Park, MD, PhD, Byoung KooK Kim, MD, PhD

Blood (2006) 108 (11): 5249.

https://doi.org/10.1182/blood.V108.11.5249.5249

Published: 2006

Journal Articles

Blockage of IL-6 Mediated JAK2/STAT3 Cell Signaling Pathway by sIL-6R Effectively Inhibited the Growth of Multiple Myeloma Cell.

Ju-won Park, BA, Kwang-Sung Ahn, PhD, Young-Ju Kim, BA, Eunkyung Bae, MS, Yong-Yeol Lee, MD PhD, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Seonyang Park, MD PhD, Byoung-Kook Kim, MD PhD

Blood (2006) 108 (11): 5083.

https://doi.org/10.1182/blood.V108.11.5083.5083

Published: 2006

Journal Articles

Prognostic Implications of the Immunophenotype in Biphenotypic Acute Leukemia.

Blood (2006) 108 (11): 2319.

https://doi.org/10.1182/blood.V108.11.2319.2319

Published: 2006

Journal Articles

Leptin-Induce Proliferation Mediated by JAK/STAT and MAPK Activation in Acute Myelogenous Leukemia Cells.

Hyun Ki Park, BS, Ju Young Kim, MS, Jin Sun Yoon, BS, Eun Shil Kim, MS, Kwang Sung Ahn, Ph.D, Sung Soo Yoon, MD, Ph.D, Byoung Kook Kim, MD, Ph.D, Young Yiul Lee, MD, Ph.D

Blood (2005) 106 (11): 4273.

https://doi.org/10.1182/blood.V106.11.4273.4273

Published: 2005

Journal Articles

IgH Gene Rearrangements Are Strongly Associated with Hyperdiploidy Variant Multiple Myeloma in Korea: A Contradiction to the Pathogenetic Pathway of IgH Tranlocations in Non Hyperdiploidy Variant.

Hee Won Moon, MD, Tae Young Kim, Seong- Ho Kang, MD, Hyun-Sook Chi, MD/PhD, Eul Zu Seo, MD/PhD, Chan Jeoung Park, MD/PhD, Honggu Chun, MD/PhD, Hee Chan Kim, MD/PhD, Sung-Soo Yoon, MD/PhD, Seonyang Park, MD/PhD, Byoung Kook Kim, MD/PhD, Han Ik Cho, MD/PhD, Dong Soon Lee, MD/PhD.

Blood (2005) 106 (11): 5084.

https://doi.org/10.1182/blood.V106.11.5084.5084

Published: 2005

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) for Acute Leukemia in First Relapse or Second Remission.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Young-Shin Lee, RN, SungCheol Yun, PhD, Sung-Soo Yoon, MD, Inho Kim, MD, Seonyang Park, MD, Byoung Kook Kim, MD, Chul Won Jung, MD, Kihyun Kim, MD, Jin Seok Ahn, MD, Kyoo-Hyung Lee, MD

Blood (2005) 106 (11): 5415.

https://doi.org/10.1182/blood.V106.11.5415.5415

Published: 2005

Journal Articles

Incidences of Submicroscopic Deletions Are Variable According to Disease Entities and Chromosomal Translocations in Hematologic Malignancies: Investigation by FISH.

Hyun Jung Min, Hee Won Moon, MD, Young-Ree Kim, MD/PhD, Sung-Soo Yoon, MD/PhD, SeonYang Park, MD/PhD, Byoung Kook Kim, MD/PhD, Hee Young Shin, MD/PhD, Hyo Sup Ahn, MD/PhD, Hee Chan Kim, MD/PhD, Han Ik Cho, MD/PhD, Dong Soon Lee, MD/PhD

Blood (2005) 106 (11): 4477.

https://doi.org/10.1182/blood.V106.11.4477.4477

Published: 2005

Journal Articles

Novel Synthetic Histone Deacetylase Inhibitor (SK-7041) Potently Inhibits Proliferation in Acute Myeloid Leukemia Cell Lines.

Young-Ju Kim, MS, Susan Guo, BA, Ju Won Park, BA, Eun Kyung Bae, MS, Kwang-Sung Ahn, PhD, Inho Kim, MD, PhD, Jong-Seok Lee, MD, PhD, Young Yiul Lee, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Sung-Soo Yoon, MD, PhD

Blood (2005) 106 (11): 4407.

https://doi.org/10.1182/blood.V106.11.4407.4407

Published: 2005

Journal Articles

The Residual Malignant Cells Could Be Masked by Therapeutic Use of Granulocyte-Colony Stimulating Factor in the Patients with AML1/ETO + Acute Myelogenous Leukemia.

Hee Won Moon, MD, Ho Young Kim, Young Ree Kim, MD, Han Ik Cho, MD, PhD, Sung-Soo Yoon, MD, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Honggu Chun, MD, PhD, Hee Chan Kim, MD, PhD, Dong Soon Lee, MD, PhD

Blood (2005) 106 (11): 4512.

https://doi.org/10.1182/blood.V106.11.4512.4512

Published: 2005

Journal Articles

Proteasome Inhibitors Can Induce Caspase-3 Activation and Apoptosis in Human CML Cell Lines.

Byung-Su Kim, MD, Chang Up Kim, MD, Young-Ju Kim, BS, Eun Kyung Bae, MS, Jinhee Kim, BS, Kwang-Sung Ahn, PhD, Seonyang Park, MD, PhD, Byoung Kook Kim, MD, PhD, Sung-Soo Yoon, MD, PhD

Blood (2004) 104 (11): 4681.

https://doi.org/10.1182/blood.V104.11.4681.4681

Published: 2004

Journal Articles

Effect of the Combination of Imatinib Mesylate (Glivec) and Curcumin in Chronicm Myeloid Leukemia Cell Line.

Young-Ju Kim, BS, Yong-Hee Choi, MS, Chang Up Kim, MD, Eun Kyung Bae, MS, Byung-Su Kim, MD, Kwang-Sung Ahn, Ph.D, Jong-Seok Lee, MD, Seonyang Park, MD, Byoung Kook Kim, MD, Sung-Soo Yoon, M.D, Ph.D

Blood (2004) 104 (11): 4685.

https://doi.org/10.1182/blood.V104.11.4685.4685

Published: 2004

NARROW

Fludarabine, Cytarabine, and Attenuated-Dose Idarubicin (m-FLAI) Induction for Elderly Patients with Acute Myeloid Leukemia: Results of a Multicenter Phase II Study,

Increased Copy Number of Interleukin-6 Receptor Gene Is Associated with Adverse Survival In Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation

Bortezomib Resistant Multiple Myeloma Cells Are Tumor Initiating Cells That Have a Stem Cell-Like Genetic Signature.

FLT3, CD32, PU.1, ERG, uPAR, and TAP2 Are Strongly Associated with the Progression of Chronic Myeloid Leukemia and Combination of Small Interference RNA of FLT3 and STI571 Synergistically Induced Apoptosis of K562 Cells

Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms of Both Donor and Recipient Can Modify the Rate of Recurrence in Allogeneic Hematopoietic Stem Cell Transplantation.

DAAM2 Polymorphism and Allogeneic Hematopoietic Stem Cell Transplantation.

Human Leukocyte Antigens of A33, B58 or DR7 Decrease the Treatment-Related Mortality in HLA-Matched Sibling Hematopoietic Stem Cell Transplantation in Association with Heat Shock Protein 70-Hom Polymorphisms.

Pharmacokinetics and Tolerability of Intravenous Busulfan in Hematopoietic Stem Cell Transplantation.

Blockage of IL-6 Mediated JAK2/STAT3 Cell Signaling Pathway by sIL-6R Effectively Inhibited the Growth of Multiple Myeloma Cell.

Prognostic Implications of the Immunophenotype in Biphenotypic Acute Leukemia.

Leptin-Induce Proliferation Mediated by JAK/STAT and MAPK Activation in Acute Myelogenous Leukemia Cells.

IgH Gene Rearrangements Are Strongly Associated with Hyperdiploidy Variant Multiple Myeloma in Korea: A Contradiction to the Pathogenetic Pathway of IgH Tranlocations in Non Hyperdiploidy Variant.

Allogeneic Hematopoietic Cell Transplantation (HCT) for Acute Leukemia in First Relapse or Second Remission.

Incidences of Submicroscopic Deletions Are Variable According to Disease Entities and Chromosomal Translocations in Hematologic Malignancies: Investigation by FISH.

Novel Synthetic Histone Deacetylase Inhibitor (SK-7041) Potently Inhibits Proliferation in Acute Myeloid Leukemia Cell Lines.

The Residual Malignant Cells Could Be Masked by Therapeutic Use of Granulocyte-Colony Stimulating Factor in the Patients with AML1/ETO + Acute Myelogenous Leukemia.

Proteasome Inhibitors Can Induce Caspase-3 Activation and Apoptosis in Human CML Cell Lines.

Effect of the Combination of Imatinib Mesylate (Glivec) and Curcumin in Chronicm Myeloid Leukemia Cell Line.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only